ArticleBiomolecules2022

Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants.

Han-Gang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.